Safety, Tolerability, Pharmacokinetics (PK), and Food Effect of MK-7762 in Healthy Adults
Status:
Recruiting
Trial end date:
2024-04-06
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to assess the safety, tolerability, and pharmacokinetics
of single and then multiple doses of MK-7762 (TBD09) in healthy volunteers in the context of
a first-in-human study. The effect of food on the rate and extent of absorption of a single
oral dose of MK-7762 (TBD09) will also be evaluated.